ClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor Accessory
April 29, 2024 08:00 ET
|
ClearPoint Neuro, Inc.
FDA Clearance of Prism Bone Anchor Accessory will expand use of the ClearPoint Prism® Neuro Laser Therapy to Operating Room
Kratos Defense & Security Solutions Schedules First Quarter 2024 Earnings Conference Call for Tuesday, May 7th
April 29, 2024 08:00 ET
|
Kratos Defense & Security Solutions, Inc.
SAN DIEGO, April 29, 2024 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS), a Technology Company in the Defense, National Security and Global Markets, announced today...
INmune Bio Inc. Completes First Cohort and Initiates Second Cohort of Phase 1/2 Study of INKmune™ Natural Killer Cell Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer
April 29, 2024 08:00 ET
|
INmune Bio, Inc.
Boca Raton, Florida, April 29, 2024 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the...
Fenbo Holdings Limited Reports Full Year 2023 Financial Result
April 29, 2024 08:00 ET
|
Fenbo Holdings Limited
Hong Kong, April 29, 2024 (GLOBE NEWSWIRE) -- Fenbo Holdings Limited (the "Company" or "Fenbo"), an established original equipment manufacturer (OEM) for a global home essential company, producing...
SAI.TECH Announces the Signing of an MOU with Green Agritech for Canada Manitoba Site Project
April 29, 2024 08:00 ET
|
SAI.TECH Global Corporation
SINGAPORE, April 29, 2024 (GLOBE NEWSWIRE) -- SAI.TECH Global Corporation (“SAI.TECH” or “SAI” or the “Company”) (NASDAQ: SAI, SAITW), announces the signing of a Memorandum of Understanding (MoU)...
Coda Octopus Group Announces Launch of AI-Based Digital Audio Communications System “Voice HUB-4” After Successful Tests with Naval Customers.
April 29, 2024 08:00 ET
|
Coda Octopus Group, Inc.
ORLANDO, FL, April 29, 2024 (GLOBE NEWSWIRE) -- Coda Octopus Group, Inc. (“CODA” or the “Company”) (Nasdaq: CODA), a global market leader in 3D/4D/5D/6D imaging sonar technology for real time subsea...
Iterum Therapeutics Resubmits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem
April 29, 2024 08:00 ET
|
Iterum Therapeutics PLC
--First Oral Penem in the U.S. and Second New Oral Treatment for uUTIs in Over 25 Years, if approved-- --Potential Approval Early Q4 2024-- DUBLIN, Ireland and CHICAGO, April 29, 2024 (GLOBE...
Auddia Announces Closing of $2.3M PIPE to Eliminate Debt and Regain Nasdaq Compliance
April 29, 2024 08:00 ET
|
Auddia Inc.
BOULDER, CO, April 29, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Auddia Inc. (NASDAQ:AUUD) (NASDAQ:AUUDW) ("Auddia" or the "Company"), a developer of a proprietary AI platform for audio and...
Soleno Therapeutics Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome (PWS)
April 29, 2024 08:00 ET
|
Soleno Therapeutics
First Ever Breakthrough Designation for a Drug Being Developed for PWS Designation is Based on Data from the Phase 3 Program for DCCR Planned Submission of a New Drug Application (NDA) for...
Esperion to Participate in Upcoming May Investor Conferences
April 29, 2024 08:00 ET
|
Esperion Therapeutics, Inc.
ANN ARBOR, Mich., April 29, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the following webcasted investor events during the month of...